Need Help? Call 1­-866-­796-­7386
« back to stock screener

  HBIO stock: Harvard Bioscience, Inc.

Current Rating
Strong Buy

Previous Rating

Buy
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$4.15
Market Cap
183.6M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
2.42
P/S
1.6
Dividend %
-
P/CF
-
P/FCF
24.9
Op. Cash Flow
8.7K
FCF
0.1
Op. Margin
-1.50%
Net Margin
-4.80%
ROE
-7.40%
ROI
-6.10%
ROA
-3.70%
EPS Growth
-47.00%
Current Ratio
2.2
Debt/Equity
59.60%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Pharmacyte Biotech Inc (PMCB) $2.01 - - 18.9M Strong Buy
Journey Medical Corp (DERM) $3.74 - - 43.3M Strong Buy
Jazz Pharmaceuticals PLC (JAZZ) $123.41 - - 8.13B Strong Buy
Interpace Biosciences Inc (IDXG) $1.50 - - 4.1M Strong Buy
Sonoma Pharmaceuticals Inc (SNOA) $0.14 - - 2.3M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More